Coronavirus
Johnson & Johnson Starts Testing Their One Dose Coronavirus Vaccine
US pharmaceutical firm Johnson & Johnson said Wednesday it has launched Phase 3 trial for its COVID-19 vaccine candidate.
The trial will enroll up to 60,000 volunteers across three continents to study the safety and efficacy of a single vaccine dose versus placebo in preventing the novel coronavirus.
Chairman and CEO Alex Gorsky said in a statement the firm will hold “standards of safety” and “transparency” during the trial.
New Jersey-based company said it aims to provide one billion doses of a successful vaccine each year.
While delivery of a cure to millions of people around the world remains an issue, the firm said its vaccine, if successful, would not require new infrastructure to get it to the people who need it because it is expected to remain stable for two years at minus 20 degrees Celsius (minus 4 F).
Johnson & Johnson’s COVID-19 vaccine candidate will get help from a technology platform that was also used to develop and manufacture an approved Ebola vaccine and construct its HIV vaccine candidates.
The platform has been used to vaccinate more than 100,000 people to date across various vaccine programs.
While the number of global COVID-19 cases is above 31.6 million as of Wednesday, more than 970,000 people have lost their lives, according to Johns Hopkins University data.
Johnson & Johnson’s stock price was up by 2.1% at $147.23 per share at the New York Stock Exchange before market opening, after it ended Tuesday at $144.21 per share.
Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram
-
Business2 weeks agoTHE HANDSHAKE THAT BECAME A NOOSE: How Tuju’s Alleged Intimate Access to EADB’s Yeda Apopo Produced a Sh294 Million Deal With No Written Contract, and Why That Trust Destroyed an Empire
-
Investigations7 days agoForged Legacy: How Kaplan and Stratton’s Peter Gachuhi Is Accused of Faking a Top AG’s Will as State Claims Damning Evidence
-
News2 weeks agoMen Linked to Akasha Drug Dynasty Charged With Death Threats and Assault at Nairobi Nightclub
-
Business7 days agoHow Firm Linked To Mombasa Tycoon Jaffer Was Allowed To Import Fuel At Bloated Price And Set To Make Billions In Profits From Iranian War Crisis In Kenya
-
News2 weeks agoCity Lawyer Kimani Wachira Caught Up In Bribery Web Fights Claims
-
News6 days agoTreasury Hands Sh358M Brief to Eric Gumbo’s Firm While Bypassing Standard Rules — and the Lawyer Is Already Deep Inside Ruto’s State Machine
-
Business6 days agoSold And Abandoned: How Diageo and Asahi Are Locking Kenya’s EABL Minority Shareholders Out Of East Africa’s Biggest Corporate Heist
-
Business1 week agoTHE BANK THAT BROKE THE TRUCKER: How NCBA’s Asset Financing Empire Is on Trial Before London’s Most Feared Arbitral Tribunal
